California's Stem Cell and Gene Therapy Program Could Take an Indirect Hit from a New Trumpian Order
The move by the NIH could mean recipients of CIRM awards would lose existing NIH cash
The Trump administration took action this week that could make many of California’s research institutions decide to step away from awards from the state’s $12 billion stem cell and gene therapy program.
The Trump move could mean that the California institutions would lose federal funding if they engage in activities that the administrati…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.